Gritstone Bio, INC 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
GRTSQ
Gritstone Bio, INCGritstone Bio's Q2 2024 results reveal ongoing operating losses and a need for additional capital, raising concerns about the company's ability to continue as a going concern.
GRTSQ
Gritstone Bio, INC10-Q: Gritstone Bio Reports Q1 2024 Results, Faces Going Concern Uncertainty Despite Recent Financing
Gritstone Bio's Q1 2024 results show a net loss of $40.4 million and highlight substantial doubt about the company's ability to continue as a going concern despite a recent $32.5 million capital raise.